Search

everythinglearnresearchcommunity

for

Search:↓

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

The best way to treat androgenetic alopecia, a common type of hair loss, is through early intervention and a comprehensive approach, but some supplements may reduce the effectiveness of medical treatments.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

SEREVELLE safely and effectively promotes hair growth in adults with thinning hair.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.

The laser system can safely improve recovery and quality of life for cervical cancer patients after surgery.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Combining hyaluronic acid and oxygen may help improve urinary incontinence in menopausal women.

Increased calcium in hair may signal early bone health issues in menopausal women.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

Age, sex, BMI, menopause, and specific genes affect hair density in East Asians.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.